Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Ward, MD
Medicago
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundación Fundamos
Buenos Aires, Argentina
- Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Buenos Aires, Argentina
- Mautalen Salud E Investigación (expertia Sa)
Buenos Aires, Argentina
- Sanatorio Allende
Córdoba, Argentina
- Clinica Mayo de Umcb Srl
San Miguel de Tucumán, Argentina
- Instituto de Pesquisas Clinicas L2ip
Brasília, Brazil
- Unidade Hospital Do Rocio
Campo Largo, Brazil
- Santa Casa de Misericordia de Belo Horizonte
Minas Gerais, Brazil
- Centro de Pesquisa Clinica - Hospital Moinhos de Vento
Porto Alegre, Brazil
- Ibpclin Instituto Brasil de Pequisa Clinica
Rio de Janeiro, Brazil
- Fundação Faculdade Regional de Medicina de Sao Jose Do Rio Preto
São Paulo, Brazil
- Azidus Brasil Pesquisa E Desenvolvimento Ltda
Valinhos, Brazil
- Care Clinic
Red Deer, Alberta, Canada
- Iwk Health Centre- Dalhousie University-Canadian Center for Vaccinology
Halifax, Nova Scotia, Canada
- Aggarwal and Associates Ltd
Brampton, Ontario, Canada
- Dawson Clinical Research Inc.
Guelph, Ontario, Canada
- Skds Research Inc.
Newmarket, Ontario, Canada
- Lmc Clinical Research Inc. (cpu)
Toronto, Ontario, Canada
- Manna Research Toronto
Toronto, Ontario, Canada
- Manna Research (quebec)
Lévis, Quebec, Canada
- Manna Research (mirabel)
Mirabel, Quebec, Canada
- Mcgill University Health Centre Vaccine Study Centre
Pierrefonds, Quebec, Canada
- Chu de Québec-Université Laval
Québec, Quebec, Canada
- Diex Research Quebec Inc.
Québec, Quebec, Canada
- Diex Recherche Joliette
Saint-Charles-Borromée, Quebec, Canada
- Diex Recherche Sherbrooke
Sherbrooke, Quebec, Canada
- Q&t Research Sherbrooke Inc.
Sherbrooke, Quebec, Canada
- Investigación Biomédica Para El Desarrollo de Fármacos, S.A. de C.V.
Aguascalientes, Mexico
- Centro Para El Desarrollo de la Medicina Y de Asistencia Médica Especializada S.C.
Culiacán, Mexico
- Rm Pharma Specialists S.A. de C.V.
Mexico City, Mexico
- Centro Multidisciplinario Para El Desarrollo Especializado de la Investigación Clínica En Yucatan S.C.P. (cemdeicy S.C.P.)
Mérida, Mexico
- Integra Rgh Centro de Investigacion, Clinica de Ozonoterapia Rgh Ac
Puebla City, Mexico
- Sociedad de Metabolismo Y Corazon S.C (someco)
Veracruz, Mexico
- Investigación Biomédica Para El Desarrollo de Fármacos, S.A. de C.V.
Zapopan, Mexico
- Nhs Grampian
Aberdeen, United Kingdom
- Synexus Midlands Clinical Research Centre
Birmingham, United Kingdom
- University Hospital Southampton Nhs Foundation Trust (uhs)
Bournemouth, United Kingdom
- Public Health Wales
Cardiff, United Kingdom
- Synexus Wales Drs
Cardiff, United Kingdom
- Mid and South Essex Nhs Foundation Trust
Chelmsford, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Nov 2020
- Primary completion
- 25 Aug 2021
- Completion
- 30 Apr 2022
- Last update posted
- 6 Apr 2022
- Registered enrollment
- 30,918
- Registry id
- NCT04636697
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.